
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
SSE:600329.SS
Overview | Financials
Company Name | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited |
Symbol | 600329.SS |
Currency | CNY |
Price | 34.65 |
Market Cap | 22,923,560,306 |
Dividend Yield | 3.04% |
52-week-range | 26.16 - 39.05 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Lei Wang |
Website | https://www.zhongxinp.com |
An error occurred while fetching data.
About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD